ImaginAb is a biotech company based in Inglewood, CA that specializes in innovative technologies for immuno-oncology patient care. Their advanced imaging agents and radiopharmaceutical therapy products aim to provide physicians with a comprehensive understanding of a patient's immune status, allowing for more targeted and effective treatments. With a focus on challenging the status quo, creating groundbreaking solutions, and transforming patient care, ImaginAb is at the forefront of advancing immunotherapy worldwide.
Using cutting-edge CD8 ImmunoPET imaging technology, ImaginAb's minibody antibodies scan patients from head to toe, providing detailed insights into their immune response before, during, and after treatment. Additionally, their RPT platform utilizes minibody and cys-diabodies to deliver targeted radiation therapy, specifically killing tumor cells. With a pipeline of next-generation biotech innovations and a team of dedicated experts, ImaginAb is reimagining the future of immuno-oncology and revolutionizing the way cancer patients are cared for.
Generated from the website